English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Received February 24, 2017 Accepted May 22, 2017 As hepatitis B virus (HBV) can be reactivated in HBV carriers and infected patients during and after they take a course of immunosuppressant drugs and chemotherapy, it is necessary to follow-up the patients regularly. However, there are no reports on a system for following up patients during and after using immunosuppressant drugs and steroids. We started a follow-up system of HBV reactivation for patients during and after using immunosuppressant drugs, chemotherapy and steroids from June 2015. We extracted target patients and their HBV inspection status from electronic medical records by using data warehouse CLISTA!SEARCH every month and if a doctor did not inspect accurately we would send an e-mail requesting an HBV inspection. In June 2015, the number of sent e-mails was 177, but the number gradually decreased, and it was 27 in January 2016. We investigated the implementation rate of hepatitis B reactivation measures from February 2016 to August 2016, it was almost 98%, so we consider it is an effective system.

Construction and Verification of a System to Prevent Hepatitis B Virus Reactivation